You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VEGF Trap-Eye

Showing 1 - 25 of 6,323
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Macular Degeneration (AMD) Post-marketing Surveillance in Japan

Completed
  • Macular Degeneration
  • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Japan
    (unnamed)
Jan 9, 2023

Aflibercept in Routine Clinical Practice in Diabetic Macular

Completed
  • Macular Edema
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
  • Multiple Locations, United Kingdom
    (unnamed)
Nov 1, 2021

Diabetic Macular Edema Trial in Ahmedabad (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

Not yet recruiting
  • Diabetic Macular Edema
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Ahmedabad, Gujarat, India
    Raghudeep Eye Hospital
Aug 19, 2022

Learn More About How Drug Aflibercept Works in Canadian Reduced

Active, not recruiting
  • Myopic Choroidal Neovascularization
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Canada
    Many Locations
Jul 25, 2022

g Medical Records to Learn More About Treat-and-extend With

Completed
  • Neovascular Age-related Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Belgium
    Many Locations
Jun 9, 2022

Learn More About How Well Aflibercept 8 mg Works in Treating

Not yet recruiting
  • Visual Impairment
  • +2 more
  • Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Australia
  • +5 more
Oct 4, 2023

Use of Aflibercept Injections Into Eye for Treatment of Eye

Recruiting
  • Retinal Disease
  • Aflibercept (BAY86-5321, Eylea)
  • Multiple Locations, Mexico
    Many locations
Aug 22, 2022

Wet Age-related Macular Degeneration or Diabetic Macular Edema

Completed
  • Macular Degeneration
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Argentina
  • +3 more
Jun 24, 2021

Intravitreal Aflibercept in Wet Macular Degeneration in Greece

Completed
  • Choroidal Neovascularization
  • Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Greece
    Many Locations
Nov 23, 2020

Intravitreal Aflibercept Treatment in Diabetic Macular Edema

Completed
  • Diabetic Retinopathy
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, France
    (unnamed)
Nov 3, 2020

Macular Edema Secondary to Retinal Vein Occlusion Trial in Worldwide (Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose,

Not yet recruiting
  • Macular Edema Secondary to Retinal Vein Occlusion
  • Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
  • +3 more
  • Fullerton, California
  • +311 more
Apr 28, 2023

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet

Completed
  • Wet Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, France
    (unnamed)
Apr 15, 2020

Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

Not yet recruiting
  • Macular Degeneration, Age Related
  • +4 more
  • VISUPRIME
  • Placebo
  • Perugia, PG, Italy
    Ospedale Santa Maria della Misericordia
Dec 22, 2022

Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept

Not yet recruiting
  • Diabetic Macular Edema
  • +2 more
  • Vitrectomy combined with ILM peeling
  • Conbercept intravitreal injection
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Feb 14, 2023

Macular Degeneration Trial in Worldwide (Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321))

Completed
Has Results
  • Macular Degeneration
  • Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Strathfield, New South Wales, Australia
  • +38 more
May 12, 2020

Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

Recruiting
  • Thyroid Eye Disease
  • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
  • +2 more
  • Boston, Massachusetts
    Mass Eye and Ear
Feb 8, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Intravitreal Aflibercept in Routine Clinical Practice Based on

Completed
  • Macular Degeneration
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Germany
    Many locations
Jan 8, 2020

Proliferative Diabetic Retinopathy, Vitreous Hemorrhage Trial in Canada, United States (2-mg Intravitreous Aflibercept

Completed
Has Results
  • Proliferative Diabetic Retinopathy
  • Vitreous Hemorrhage
  • 2-mg Intravitreous Aflibercept Injection
  • Prompt Vitrectomy Plus Panretinal Photocoagulation
  • Campbell, California
  • +61 more
Mar 24, 2021

Retinopathy of Prematurity Trial in Worldwide (aflibercept, laser photocoagulation)

Active, not recruiting
  • Retinopathy of Prematurity
  • Phoenix, Arizona
  • +51 more
Dec 20, 2021

Following Intensive Anti-VEGF Therapy in Wet AMD

Completed
  • Age-Related Macular Degeneration
  • Budapest, Hungary
  • +1 more
Dec 28, 2022

Intravitreal Aflibercept Injection in Clinical Practice in naïve

Completed
  • Macular Degeneration
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Spain
    Many locations
Dec 4, 2019

EYLEA for Myopic Choroidal Neovascularization

Completed
  • Choroidal Neovascularization
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Japan
    (unnamed)
Sep 18, 2019

Neovascular Age-related Macular Degeneration Trial in Beijing (RC28-E)

Completed
  • Neovascular Age-related Macular Degeneration
  • RC28-E
  • Beijing, China
    Beijing Tongren Hospital .Cmu
Apr 26, 2021

Macular Degeneration Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

Completed
Has Results
  • Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Wien, Austria
  • +70 more
Jun 1, 2021